BRCA2 and prostate cancer: Risbridger Risbridger GP GP Taylor Taylor RA RA Clouston Clouston D D Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis Eur Urol Eur Urol 2015 2015 67 67 496 496 503 503 supplied-pmid 25154392?